BOLT vs BRO · rev $7.7M vs P/E 30, rev $4.80B
Bolt Biotherapeutics (BOLT) versus Brown & Brown Inc (BRO) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
BOLT currently screens at market cap $11.3M. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Not investment advice. Open the BOLT and BRO stock pages for the full models.
Not investment advice.